Growing fast, with headroom
Healthcare in Bahrain is expanding rapidly with a focus on developing centres of medical excellence. At the same time, a healthcare industry analysis reports that Bahrain has the lowest density of health workers per capita in the Gulf Cooperation Council (GCC), suggesting significant room for expansion (WHO 2017). Hospitals in Bahrain may have the lowest density, but Bahrain medical centres are primed for expansion with an excellent workforce. With a market on the rise and a workforce ripe for development, now is the time to take advantage of healthcare investment opportunities in Bahrain and invest in research facilities and hospitals in Bahrain.
3.4%
GDP contribution in 2019
76 million
GCC population by 2050
USD 85 billion
size of GCC healthcare market by 2021
USD 270 million
investment in Phase 1 of King Abdullah Medical City
Your business is in safe hands
Bahrain provides the perfect combination of training, talent, and technology to make the healthcare sector a promising financial opportunity for you across the entire region.
World-class health institutions
Prominent health training institutions already operate in Bahrain, providing solid foundations for further healthcare investment. Our growing healthcare sector is already home to The Royal College of Surgeons in Ireland, the College of Health Science, and the Arabian Gulf University, which plans to expand into King Abdullah Medical City with a medical school campus and a new teaching hospital by the end of 2020.
Superb talent pool
Bahrain is perfectly placed to attract a new breed of talent for the healthcare sector. We have a young, educated population with the region’s highest private sector engagement and high-quality, competitively-priced living.
An excellent technology base
Bahrain is well placed to capitalise on the fastest-expanding global healthcare sector: medical technology. Through technology transformation, we offer a well-established and evolving ICT ecosystem, with considerable support for start-ups. Improved technology also provides more research data to enhance medical practices.
The ideal location
Bahrain’s strategic location gives it a strong market position. Our position at the centre of the GCC makes us a magnet for regional healthcare services. The Kingdom is just a one-hour flight from large neighbouring markets like the UAE and Saudi Arabia, where the combination of emerging chronic lifestyle diseases and middle-class healthcare consumption suggests that expenditure in the healthcare sector is forecast to increase significantly.
Success Stories
KIMS Healthcare Group
KIMS is revolutionising the healthcare sector through quality-led systems and health practices. The group has a strong GCC presence with a network of hospitals and healthcare centres. Its professionals offer experience, expertise, quality care, cutting-edge facilities and world-class treatment protocols.
ORPEA
One of Europe’s largest healthcare companies in dependency care, ORPEA specialises in long- and short-term physical and mental care at 774 health facilities with around 80,000 beds. It is a growing presence in the healthcare sector as it expands in Asia and more specifically in the Gulf.
Royal Hospital for Women and Children (established 2019)
The Royal Hospital for Women and Children is the first of its kind in the Kingdom of Bahrain. The private hospital is dedicated solely to women’s care and pediatrics with specialties including neonatal and antenatal services, gynecology, endoscopy, bone denstimetry, breast cancer screening, and IVF.
Offers a full range of clinical services for women – including the only Neonatal Intensive Care Unit (NICU) in the island’s numerous private hospitals.
Bahrain Pharma (established 2020)
A first of its kind strategic project in the Bahraini pharmaceutical industry. Bahrain Pharma is the first large-scale fully operational pharmaceuticals manufacturer in Bahrain. Bahrain Pharma’s manufacturing will currently be focused on vegetarian soft gel capsules and syrups as well as nutraceuticals. they have started with two production lines with a total annual production capacity of 600 million soft gel capsules and 20 million syrup bottles with the potential to expand production capacity to three additional production lines of soft gel capsules.
